Keyphrases
Accreditation Council for Graduate Medical Education (ACGME)
14%
Adjuvant Therapy
12%
Angiographic Patterns
14%
Association of Program Directors in Radiology
12%
Chemoembolization
31%
Chief Resident
80%
COVID-19 Pandemic
16%
Diagnostic Radiology
15%
Embolization
31%
Fellow Education
12%
Gastrointestinal Bleeding
12%
Hepatic Arterial Chemoembolization
29%
Hepatic Malignancy
25%
Hepatic Metastasis
17%
Hepatocellular Carcinoma
14%
Interventional Imaging
12%
Interventional Oncology
31%
Interventional Radiologist
18%
Interventional Radiology
40%
Interventional Radiology Residency
22%
Job Market
22%
Liver Transplantation
14%
Locoregional
12%
Locoregional Therapy
12%
Long-term Survival
14%
Metastatic Lesions
12%
Neuroendocrine Tumor
12%
North America
21%
Oncology Education
12%
Online Survey
16%
Overall Survival
16%
Overall Survival Time
13%
Program Directors
12%
Progression-free Survival
14%
Radioembolization
18%
Radiology
84%
Radiology Residency
15%
Radiology Residents
19%
Radiology Training
30%
Reporting Criteria
25%
Residency Program
24%
Resident Education
16%
Response Rate
15%
Single Center
12%
Terminology Standardization
25%
Training Program
17%
Transarterial Chemoembolization
13%
Transcatheter Intervention
37%
Trauma
12%
Tumor Ablation
12%
Medicine and Dentistry
Abscess Drainage
12%
Adjuvant Therapy
12%
Angiography
9%
Arterial Embolization
7%
Artery
12%
Biopsy
12%
Cancer
25%
Carcinoid
5%
Common Bile Duct Stone
12%
Common Hepatic Artery
7%
COVID-19
17%
Decision Making
12%
Disease
11%
Embolization
33%
Fallopian Tube
12%
Flexibility
9%
Gastrointestinal Bleeding
12%
Health Care
6%
Hepatic Artery Chemoembolization
8%
Hepatocellular Carcinoma
25%
Injury
12%
Interventional Radiologist
14%
Interventional Radiology
45%
Liver Metastasis
16%
Liver Transplantation
14%
Long Term Survival
12%
Medical Student
6%
Metastatic Carcinoma
14%
Metastatic Melanoma
16%
Minimally Invasive Procedure
12%
Neoplasm
15%
Neuroendocrine Tumor
12%
Nodular Melanoma
5%
Oncology
33%
Overall Survival
25%
Primary Tumor
7%
Program Director
12%
Progression Free Survival
14%
Radiodiagnosis
8%
Radioembolization
20%
Radiology
100%
Recanalization
12%
Retrospective Study
12%
Surgery
5%
Survival Time
30%
Transcatheter Arterial Chemoembolization
72%
Transcatheter Therapy
29%
Tumor Ablation
16%
Uveal Melanoma
12%